nodes	percent_of_prediction	percent_of_DWPC	metapath
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—TIMP1—osteoarthritis	0.0938	0.0938	CbGpPWpGaD
Orlistat—PLA2G7—Synthesis, secretion, and deacylation of Ghrelin—LEP—osteoarthritis	0.0743	0.0743	CbGpPWpGaD
Orlistat—PLA2G7—Synthesis, secretion, and deacylation of Ghrelin—IGF1—osteoarthritis	0.0614	0.0614	CbGpPWpGaD
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—IL1B—osteoarthritis	0.036	0.036	CbGpPWpGaD
Orlistat—PLA2G7—IL1 and megakaryotyces in obesity—MMP9—osteoarthritis	0.0339	0.0339	CbGpPWpGaD
Orlistat—FASN—Defective AMN causes hereditary megaloblastic anemia 1—GSTO1—osteoarthritis	0.022	0.022	CbGpPWpGaD
Orlistat—PLA2G4A—Arachidonic acid metabolism—PTGES—osteoarthritis	0.0209	0.0209	CbGpPWpGaD
Orlistat—PLA2G7—Peptide hormone metabolism—LEP—osteoarthritis	0.0205	0.0205	CbGpPWpGaD
Orlistat—FASN—Validated transcriptional targets of deltaNp63 isoforms—IL1A—osteoarthritis	0.0179	0.0179	CbGpPWpGaD
Orlistat—PLA2G7—Peptide hormone metabolism—IGF1—osteoarthritis	0.0169	0.0169	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—ADAMTS13—osteoarthritis	0.0148	0.0148	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—ADAMTS5—osteoarthritis	0.0139	0.0139	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—ADAMTS3—osteoarthritis	0.0139	0.0139	CbGpPWpGaD
Orlistat—DAGLB—Platelet activation, signaling and aggregation—HSPA5—osteoarthritis	0.0126	0.0126	CbGpPWpGaD
Orlistat—DAGLA—Platelet activation, signaling and aggregation—HSPA5—osteoarthritis	0.0126	0.0126	CbGpPWpGaD
Orlistat—DAGLA—Platelet activation, signaling and aggregation—TIMP1—osteoarthritis	0.012	0.012	CbGpPWpGaD
Orlistat—DAGLB—Platelet activation, signaling and aggregation—TIMP1—osteoarthritis	0.012	0.012	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—ADAMTS4—osteoarthritis	0.0118	0.0118	CbGpPWpGaD
Orlistat—FASN—AMPK Signaling—LEP—osteoarthritis	0.0108	0.0108	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00983	0.00983	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—osteoarthritis	0.00956	0.00956	CbGpPWpGaD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—osteoarthritis	0.00956	0.00956	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—MMP13—osteoarthritis	0.00924	0.00924	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—MCF2L—osteoarthritis	0.009	0.009	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—MCF2L—osteoarthritis	0.009	0.009	CbGpPWpGaD
Orlistat—CYP3A4—Tryptophan metabolism—ALDH1A2—osteoarthritis	0.00887	0.00887	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—MCF2L—osteoarthritis	0.00817	0.00817	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—IHH—osteoarthritis	0.00817	0.00817	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—IHH—osteoarthritis	0.00817	0.00817	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—MCF2L—osteoarthritis	0.00817	0.00817	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—ESR1—osteoarthritis	0.00759	0.00759	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00695	0.00695	CbGpPWpGaD
Orlistat—DAGLA—Platelet activation, signaling and aggregation—FN1—osteoarthritis	0.00682	0.00682	CbGpPWpGaD
Orlistat—DAGLB—Platelet activation, signaling and aggregation—FN1—osteoarthritis	0.00682	0.00682	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—HSPA5—osteoarthritis	0.00676	0.00676	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—HSPA5—osteoarthritis	0.00651	0.00651	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—HSPA5—osteoarthritis	0.00651	0.00651	CbGpPWpGaD
Orlistat—PNLIP—Disease—FMOD—osteoarthritis	0.00641	0.00641	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—TIMP1—osteoarthritis	0.0062	0.0062	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—TIMP1—osteoarthritis	0.0062	0.0062	CbGpPWpGaD
Orlistat—PLA2G4A—Prostaglandin Synthesis and Regulation—PTGS2—osteoarthritis	0.00616	0.00616	CbGpPWpGaD
Orlistat—FASN—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—osteoarthritis	0.00613	0.00613	CbGpPWpGaD
Orlistat—DAGLB—Platelet activation, signaling and aggregation—IGF1—osteoarthritis	0.00598	0.00598	CbGpPWpGaD
Orlistat—DAGLA—Platelet activation, signaling and aggregation—IGF1—osteoarthritis	0.00598	0.00598	CbGpPWpGaD
Orlistat—PNLIP—Disease—IHH—osteoarthritis	0.00571	0.00571	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—SMAD3—osteoarthritis	0.0056	0.0056	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—PTGS2—osteoarthritis	0.00545	0.00545	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—FMOD—osteoarthritis	0.00537	0.00537	CbGpPWpGaD
Orlistat—PLA2G4A—Endothelins—MMP1—osteoarthritis	0.00513	0.00513	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—IHH—osteoarthritis	0.00483	0.00483	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MCF2L—osteoarthritis	0.00483	0.00483	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MCF2L—osteoarthritis	0.00483	0.00483	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IHH—osteoarthritis	0.00483	0.00483	CbGpPWpGaD
Orlistat—FASN—Disease—FMOD—osteoarthritis	0.00454	0.00454	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PTGES—osteoarthritis	0.00438	0.00438	CbGpPWpGaD
Orlistat—PNLIP—Disease—TGFBI—osteoarthritis	0.00426	0.00426	CbGpPWpGaD
Orlistat—PLA2G4A—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.0041	0.0041	CbGpPWpGaD
Orlistat—FASN—Disease—IHH—osteoarthritis	0.00404	0.00404	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MCF2L—osteoarthritis	0.004	0.004	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IHH—osteoarthritis	0.004	0.004	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—MMP1—osteoarthritis	0.004	0.004	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—LEP—osteoarthritis	0.00387	0.00387	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—MMP1—osteoarthritis	0.00385	0.00385	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—MMP1—osteoarthritis	0.00385	0.00385	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—MMP2—osteoarthritis	0.00383	0.00383	CbGpPWpGaD
Orlistat—FASN—Metabolism—FMOD—osteoarthritis	0.0038	0.0038	CbGpPWpGaD
Orlistat—PNLIP—Disease—GSTO1—osteoarthritis	0.00368	0.00368	CbGpPWpGaD
Orlistat—DAGLA—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	0.00358	0.00358	CbGpPWpGaD
Orlistat—DAGLB—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	0.00358	0.00358	CbGpPWpGaD
Orlistat—PNLIP—Disease—BGN—osteoarthritis	0.00357	0.00357	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—COL9A2—osteoarthritis	0.00354	0.00354	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—COL9A2—osteoarthritis	0.00354	0.00354	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—FN1—osteoarthritis	0.00352	0.00352	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—FN1—osteoarthritis	0.00352	0.00352	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—COL9A1—osteoarthritis	0.00344	0.00344	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—COL9A1—osteoarthritis	0.00344	0.00344	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—IGF1—osteoarthritis	0.0032	0.0032	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—HSPA5—osteoarthritis	0.00318	0.00318	CbGpPWpGaD
Orlistat—FASN—Metabolism—PTGES—osteoarthritis	0.0031	0.0031	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—MMP2—osteoarthritis	0.0031	0.0031	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—GSTO1—osteoarthritis	0.00308	0.00308	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—IGF1—osteoarthritis	0.00308	0.00308	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—IGF1—osteoarthritis	0.00308	0.00308	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—TIMP1—osteoarthritis	0.00303	0.00303	CbGpPWpGaD
Orlistat—FASN—Disease—TGFBI—osteoarthritis	0.00301	0.00301	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—BGN—osteoarthritis	0.00299	0.00299	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00298	0.00298	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—COL9A2—osteoarthritis	0.00294	0.00294	CbGpPWpGaD
Orlistat—PLA2G4A—AGE/RAGE pathway—MMP9—osteoarthritis	0.00288	0.00288	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—COL9A1—osteoarthritis	0.00285	0.00285	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—MMP3—osteoarthritis	0.00277	0.00277	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—MMP3—osteoarthritis	0.00277	0.00277	CbGpPWpGaD
Orlistat—DAGLB—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoarthritis	0.00276	0.00276	CbGpPWpGaD
Orlistat—DAGLA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoarthritis	0.00276	0.00276	CbGpPWpGaD
Orlistat—FASN—Disease—GSTO1—osteoarthritis	0.00261	0.00261	CbGpPWpGaD
Orlistat—PLA2G7—Metabolism of proteins—CXCL8—osteoarthritis	0.00257	0.00257	CbGpPWpGaD
Orlistat—FASN—Disease—BGN—osteoarthritis	0.00252	0.00252	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—BMP2—osteoarthritis	0.00236	0.00236	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—BMP2—osteoarthritis	0.00236	0.00236	CbGpPWpGaD
Orlistat—FASN—Metabolism—GSTO1—osteoarthritis	0.00218	0.00218	CbGpPWpGaD
Orlistat—FASN—Metabolism—BGN—osteoarthritis	0.00211	0.00211	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—MCF2L—osteoarthritis	0.00206	0.00206	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IHH—osteoarthritis	0.00206	0.00206	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—BMP2—osteoarthritis	0.00195	0.00195	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.00195	0.00195	CbGpPWpGaD
Orlistat—PNLIP—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.00193	0.00193	CbGpPWpGaD
Orlistat—DAGLB—Hemostasis—TGFB1—osteoarthritis	0.00185	0.00185	CbGpPWpGaD
Orlistat—DAGLA—Hemostasis—TGFB1—osteoarthritis	0.00185	0.00185	CbGpPWpGaD
Orlistat—PNLIP—Disease—SMAD3—osteoarthritis	0.00175	0.00175	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—FN1—osteoarthritis	0.00172	0.00172	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.00169	0.00169	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—HSPA5—osteoarthritis	0.00164	0.00164	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MMP3—osteoarthritis	0.00163	0.00163	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MMP3—osteoarthritis	0.00163	0.00163	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—FMOD—osteoarthritis	0.00163	0.00163	CbGpPWpGaD
Orlistat—DAGLB—GPCR downstream signaling—CXCL8—osteoarthritis	0.00157	0.00157	CbGpPWpGaD
Orlistat—DAGLA—GPCR downstream signaling—CXCL8—osteoarthritis	0.00157	0.00157	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TIMP1—osteoarthritis	0.00156	0.00156	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—IGF1—osteoarthritis	0.0015	0.0015	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—SMAD3—osteoarthritis	0.00148	0.00148	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—SMAD3—osteoarthritis	0.00148	0.00148	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—CXCL8—osteoarthritis	0.00142	0.00142	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—CXCL8—osteoarthritis	0.00142	0.00142	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.0014	0.0014	CbGpPWpGaD
Orlistat—FASN—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.00136	0.00136	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MMP3—osteoarthritis	0.00135	0.00135	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PTGES—osteoarthritis	0.00133	0.00133	CbGpPWpGaD
Orlistat—CYP3A4—Biological oxidations—GSTO1—osteoarthritis	0.00128	0.00128	CbGpPWpGaD
Orlistat—CYP3A4—Metapathway biotransformation—GSTO1—osteoarthritis	0.00126	0.00126	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—LEP—osteoarthritis	0.00126	0.00126	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—LEP—osteoarthritis	0.00126	0.00126	CbGpPWpGaD
Orlistat—FASN—Disease—SMAD3—osteoarthritis	0.00124	0.00124	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—SMAD3—osteoarthritis	0.00123	0.00123	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IHH—osteoarthritis	0.00121	0.00121	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MCF2L—osteoarthritis	0.00121	0.00121	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—ESR1—osteoarthritis	0.00121	0.00121	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—ESR1—osteoarthritis	0.00121	0.00121	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—FN1—osteoarthritis	0.00119	0.00119	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—FN1—osteoarthritis	0.00119	0.00119	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—LEP—osteoarthritis	0.00105	0.00105	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IGF1—osteoarthritis	0.00104	0.00104	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—IGF1—osteoarthritis	0.00104	0.00104	CbGpPWpGaD
Orlistat—PNLIP—Disease—PTGS2—osteoarthritis	0.00103	0.00103	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.00101	0.00101	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—ESR1—osteoarthritis	0.001	0.001	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—FN1—osteoarthritis	0.000988	0.000988	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—MMP1—osteoarthritis	0.00097	0.00097	CbGpPWpGaD
Orlistat—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.000946	0.000946	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—GSTO1—osteoarthritis	0.000936	0.000936	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—BGN—osteoarthritis	0.000907	0.000907	CbGpPWpGaD
Orlistat—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	0.000902	0.000902	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—COL9A2—osteoarthritis	0.000892	0.000892	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—FN1—osteoarthritis	0.000885	0.000885	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IGF1—osteoarthritis	0.000866	0.000866	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—COL9A1—osteoarthritis	0.000866	0.000866	CbGpPWpGaD
Orlistat—PNLIP—Metabolism—PTGS2—osteoarthritis	0.000859	0.000859	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—CXCL8—osteoarthritis	0.00084	0.00084	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—CXCL8—osteoarthritis	0.00084	0.00084	CbGpPWpGaD
Orlistat—DAGLA—Signaling by GPCR—IL6—osteoarthritis	0.000799	0.000799	CbGpPWpGaD
Orlistat—DAGLB—Signaling by GPCR—IL6—osteoarthritis	0.000799	0.000799	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—IGF1—osteoarthritis	0.000775	0.000775	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—MMP9—osteoarthritis	0.00076	0.00076	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—MMP9—osteoarthritis	0.00076	0.00076	CbGpPWpGaD
Orlistat—PNLIP—Disease—TGFB1—osteoarthritis	0.000741	0.000741	CbGpPWpGaD
Orlistat—FASN—Disease—PTGS2—osteoarthritis	0.000725	0.000725	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—CXCL8—osteoarthritis	0.000696	0.000696	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—MMP3—osteoarthritis	0.000696	0.000696	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—MMP9—osteoarthritis	0.00063	0.00063	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—TGFB1—osteoarthritis	0.000626	0.000626	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—TGFB1—osteoarthritis	0.000626	0.000626	CbGpPWpGaD
Orlistat—FASN—Metabolism—PTGS2—osteoarthritis	0.000608	0.000608	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—BMP2—osteoarthritis	0.000593	0.000593	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000585	0.000585	CbGpPWpGaD
Orlistat—PNLIP—Disease—IL6—osteoarthritis	0.000559	0.000559	CbGpPWpGaD
Orlistat—FASN—Disease—TGFB1—osteoarthritis	0.000524	0.000524	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—TGFB1—osteoarthritis	0.000519	0.000519	CbGpPWpGaD
Orlistat—DAGLB—Signaling Pathways—IL6—osteoarthritis	0.000472	0.000472	CbGpPWpGaD
Orlistat—DAGLA—Signaling Pathways—IL6—osteoarthritis	0.000472	0.000472	CbGpPWpGaD
Orlistat—PLA2G4A—Hemostasis—TGFB1—osteoarthritis	0.000465	0.000465	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MMP3—osteoarthritis	0.000411	0.000411	CbGpPWpGaD
Orlistat—FASN—Disease—IL6—osteoarthritis	0.000395	0.000395	CbGpPWpGaD
Orlistat—PNLIP—Signaling Pathways—IL6—osteoarthritis	0.000391	0.000391	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—FMOD—osteoarthritis	0.000382	0.000382	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—SMAD3—osteoarthritis	0.000372	0.000372	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—CXCL8—osteoarthritis	0.000358	0.000358	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—LEP—osteoarthritis	0.000318	0.000318	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PTGES—osteoarthritis	0.000311	0.000311	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—ESR1—osteoarthritis	0.000304	0.000304	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—FN1—osteoarthritis	0.0003	0.0003	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IGF1—osteoarthritis	0.000263	0.000263	CbGpPWpGaD
Orlistat—PLA2G4A—Metabolism—PTGS2—osteoarthritis	0.000261	0.000261	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—GSTO1—osteoarthritis	0.000219	0.000219	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—BGN—osteoarthritis	0.000212	0.000212	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—CXCL8—osteoarthritis	0.000211	0.000211	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling by GPCR—IL6—osteoarthritis	0.000201	0.000201	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—MMP9—osteoarthritis	0.000191	0.000191	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—TGFB1—osteoarthritis	0.000158	0.000158	CbGpPWpGaD
Orlistat—PLA2G4A—Signaling Pathways—IL6—osteoarthritis	0.000119	0.000119	CbGpPWpGaD
Orlistat—CYP3A4—Metabolism—PTGS2—osteoarthritis	6.11e-05	6.11e-05	CbGpPWpGaD
